Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort study.
about
Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic reviewVirological outcomes and drug resistance in Chinese patients after 12 months of 3TC-based first-line antiretroviral treatment, 2011-2012High prevalence of the K65R mutation in HIV-1 subtype C infected patients failing tenofovir-based first-line regimens in South AfricaChanging predictors of mortality over time from cART start: implications for care.Predictors of virologic failure in HIV-1-infected adults receiving first-line antiretroviral therapy in 8 provinces in ChinaRates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trialWho is accessing public-sector anti-retroviral treatment in the Free State, South Africa? An exploratory study of the first three years of programme implementationThe experience of "medicine companions" to support adherence to antiretroviral therapy: quantitative and qualitative data from a trial population in UgandaViremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa.Effectiveness of first-line antiretroviral therapy in the IPEC cohort, Rio de Janeiro, Brazil.Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcomeAssociation between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.Living situation affects adherence to combination antiretroviral therapy in HIV-infected adolescents in Rwanda: a qualitative study.Predictors of raised viral load during antiretroviral therapy in patients with and without prior antiretroviral use: a cross-sectional study.Outcomes of antiretroviral treatment in HIV-infected adults: a dynamic and observational cohort study in Shenzhen, China, 2003-2014.Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapyPatients' demographic and clinical characteristics and level of care associated with lost to follow-up and mortality in adult patients on first-line ART in Nigerian hospitals.Antiretroviral treatment adherence and its determinants in Sub-Saharan Africa: a prospective study at Yaounde Central Hospital, Cameroon.Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South AfricaSelf-Report Measures in the Assessment of Antiretroviral Medication Adherence: Comparison with Medication Possession Ratio and HIV Viral Load.Scaling up implementation of ART: Organizational culture and early mortality of patients initiated on ART in Nairobi, Kenya.
P2860
Q26823588-BD718A1A-E731-449A-A3C1-B2C29E2DA3BDQ28539652-823FCDF3-DABC-4A32-A3FF-72290D04EA07Q28543358-EEB44676-7E8F-4100-B3AE-630E5863E926Q33564975-D11234A2-DE89-4B4B-9B8D-9C958D72AAE1Q33586369-01392C30-4254-46E8-A251-91DC9206C55BQ33590533-7CC4CCD4-0879-4B03-B8C9-F86C05A5A97CQ33622913-5B40DDDF-E25B-40F8-AB60-952A55F4D3B3Q33648147-BC970ADC-B503-497E-AB82-E0F57D474D84Q33952538-E6043821-00B3-463B-B87D-DFFD56FF9D86Q34153838-BA67B19F-623C-4E13-90D2-E6E7F80AFC1DQ34292437-01556D45-F4AC-4EE3-80FA-E1F99380B3E5Q34630565-A0751336-E541-4E84-B16F-BC30C6F1E32EQ34661851-55682E63-735E-433B-B8FC-9DECD047F3EDQ34963950-94030BB4-C59A-49CE-8CA7-47A8F08935CEQ35640523-022BE096-00F1-4B80-87FC-CA2555E96993Q36090721-61EECFBD-1548-4A79-9AD2-B965248E7864Q36386792-C52B84AB-CE89-42FD-8CF6-0FE24A585099Q37404827-41929CB5-84F5-4D0D-973A-564CCE407F77Q37461877-6FDA5A1B-C444-4073-932B-C6E6E8077CAFQ41649806-8E19ACB5-7516-4F0D-8BC0-6EF278816DC7Q47223924-C9F567EF-DB66-4BCF-830B-0BBE946E4094
P2860
Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort study.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Risk factors for poor virologi ...... South Africa: a cohort study.
@ast
Risk factors for poor virologi ...... South Africa: a cohort study.
@en
type
label
Risk factors for poor virologi ...... South Africa: a cohort study.
@ast
Risk factors for poor virologi ...... South Africa: a cohort study.
@en
prefLabel
Risk factors for poor virologi ...... South Africa: a cohort study.
@ast
Risk factors for poor virologi ...... South Africa: a cohort study.
@en
P2093
P2860
P50
P921
P356
P1476
Risk factors for poor virologi ...... South Africa: a cohort study.
@en
P2093
Alison D Grant
Amy L Stenson
Des J Martin
Lindiwe F Pemba
P2860
P2888
P356
10.1186/1471-2334-8-93
P577
2008-07-16T00:00:00Z
P5875
P6179
1007350573